Healthcare payors AI model risk management At Scale | Moring
AI model risk management for healthcare payors, running it at scale: the sources cited below describe how healthcare payors teams handle this running it at scale question specifically — the mechanics, the evidence and the oversight healthcare payors examiners expect at this stage.
Short answer
AI model risk management for healthcare payors, running it at scale: the sources cited below describe how healthcare payors teams handle this running it at scale question specifically — the mechanics, the evidence and the oversight healthcare payors examiners expect at this stage.
How it works
Running it at scale of ai model risk management in healthcare payors raises questions the general overview does not answer: what healthcare payors teams actually deploy at the running it at scale stage, which controls that stage adds, and what the cited authorities say about running it at scale specifically. Rather than generic definitions, this page assembles what the listed sources actually say.
Per Governing AI Across Industries, Part 2 | Perficient (perficient.com): "Learn how governance, accuracy, and KPIs differ across industries at scale. In practice, those differences become more visible in production, where accuracy, risk tolerance, performance measurement, and governance diverge. Execution is where AI agents either deliver value or fail to scale."
Per Clinical AI governance for scalable innovation in value based healthcare systems | npj Digital Medicine (nature.com): "The Collaborative Technology Adoption for Care Transformation (C-TACT) framework, developed at Southern California Permanente Medical Group (SCPMG), organizes governance across three pillars (People, Process, Technology) and four lifecycle stages (Vendor Evaluation, Pilot, Scale, Maintenance), each operationalized through a domain-weighted scorecard. Scale and Maintenance scorecards incorporate business and operational execution as weighted domains, with Analytic Hierarchy Process methods (consistency ratio 0.0037). Prospective, blinded validation is needed to establish its discriminative and predictive performance under real-world conditions."
Per UnitedHealth Group Case Study — Thndr AI (thndr.ai): "When the compliance team attempted to inventory which models qualified as SaMD under the FDA's updated framework, the exercise exposed 34 models with no current validation record and 19 more with documentation that did not meet the agency's performance monitoring requirements. 65% Reduction in validation time Automated evidence generation from pipeline metadata replaced manual documentation assembly across the portfolio. As the FDA expanded its oversight of Software as a Medical Device and CMS intensified scrutiny of automated prior authorization systems, Optum faced a fundamental governance gap: the clinical AI portfolio had grown faster than the infrastructure to govern it."
Per Senior Director, AI Lifecycle Management - Centene Corporation | Built In (builtin.com): "Summary Generated by Built In Position Purpose: Leads enterprise AI use case intake, portfolio lifecycle management, and governance process flow/operations (not policy creation) for Centene, serving as the single front door and system of record for AI from idea through production and eventual decommissioning. Owns the end-to-end AI lifecycle workflow aligned to Centene's seven-stage AI lifecycle — plan and design, data collection, build, testing and validation, integration and E2E testing, operations and monitoring, and measurement and real-world value. Leads a team of managers and individual contributors and advises senior leadership on AI portfolio health, investment prioritization, and realized value."
For the control baseline every running it at scale decision inherits — named owners, scoped credentials, policy checks before every call and an audit trail no agent can alter — see the main healthcare payors ai model risk management page at /topics/healthcare-payor-model-risk/. The running it at scale specifics above, and the 6 sources cited below, build directly on that baseline for healthcare payors.
Frequently asked questions
How should healthcare payors teams approach running it at scale of ai model risk management?
Start from the sources on this page: they describe how healthcare payors organizations handle running it at scale of ai model risk management in practice, including the controls and evidence the authorities cite. Apply the control baseline from the parent ai model risk management page first, then layer the running it at scale specifics these sources detail.
What makes running it at scale of ai model risk management different in healthcare payors?
The sources here are selected for healthcare payors relevance, so the running it at scale guidance reflects the regulatory and operational context healthcare payors teams work under, including EU AI Act. The underlying mechanics are similar in other industries, but the evidence expectations are stricter for healthcare payors deployments.
Which sources back the running it at scale guidance for ai model risk management in healthcare payors?
The list below covers 6 references selected for this page, from fiddler.ai to artificialintelligenceact.eu. Each is quoted in the body where it bears on running it at scale of ai model risk management, so every claim on this page traces to its source.